132 related articles for article (PubMed ID: 37572296)
1. Heart valve disease in primary antiphospholipid syndrome.
Niznik S; Rapoport MJ; Avnery O; Kidon M; Shavit R; Ellis MH; Agmon-Levin N
Rheumatology (Oxford); 2024 May; 63(5):1397-1402. PubMed ID: 37572296
[TBL] [Abstract][Full Text] [Related]
2. Severe Libman-Sacks endocarditis complicating antiphospholipid syndrome: a retrospective analysis of 23 operated cases.
Chalvon NB; Costedoat-Chalumeau N; Pennaforte JL; Servettaz A; Boulagnon Rombi C; Gavand PE; Lekieffre M; Le Guern V; Morel N; Cohen Aubart F; Haroche J; Mathian A; Collet JP; Piette JC; Amoura Z; Orquevaux P
Rheumatology (Oxford); 2023 Feb; 62(2):707-715. PubMed ID: 35686908
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Serbian Primary Antiphospholipid Syndrome Patients Confirmed a Strong Association Between Livedo Reticularis and Arterial Thrombosis: A National Cross-Sectional Cohort Study.
Djokovic A; Stojanovich L; Stanisavljevic N; Matic P; Colic D; Skrijelj D; Djokic S; Filipovic B
J Clin Rheumatol; 2022 Oct; 28(7):362-366. PubMed ID: 35697016
[TBL] [Abstract][Full Text] [Related]
4. Valvular heart disease in antiphospholipid syndrome.
Zuily S; Huttin O; Mohamed S; Marie PY; Selton-Suty C; Wahl D
Curr Rheumatol Rep; 2013 Apr; 15(4):320. PubMed ID: 23456852
[TBL] [Abstract][Full Text] [Related]
5. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
Kopytek M; Natorska J; Undas A
Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature.
Franco AMM; Medina FMC; Balbi GGM; Levy RA; Signorelli F
Lupus; 2020 Oct; 29(12):1528-1543. PubMed ID: 32814509
[TBL] [Abstract][Full Text] [Related]
7. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies.
Zuily S; Regnault V; Selton-Suty C; Eschwège V; Bruntz JF; Bode-Dotto E; De Maistre E; Dotto P; Perret-Guillaume C; Lecompte T; Wahl D
Circulation; 2011 Jul; 124(2):215-24. PubMed ID: 21690492
[TBL] [Abstract][Full Text] [Related]
8. IgA Antiphospholipid Antibodies and Anti-Domain 1 of Beta 2 Glycoprotein 1 Antibodies are Associated with Livedo Reticularis and Heart Valve Disease in Antiphospholipid Syndrome.
Cieśla M; Wypasek E; Undas A
Adv Clin Exp Med; 2014; 23(5):729-33. PubMed ID: 25491686
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to Domain I β
Reshetnyak TM; Cheldieva FA; Cherkasova MV; Glukhova SI; Lila AM; Nasonov EL
Dokl Biochem Biophys; 2023 Aug; 511(1):219-226. PubMed ID: 37833609
[TBL] [Abstract][Full Text] [Related]
10. Primary Antiphospholipid Syndrome with Livedo Reticularis is Linked to Female Sex and Stroke and Negatively Associated with Thyroid Disease.
Carvalho JF; de Araujo RPC; Skare TL
Curr Rheumatol Rev; 2022; 18(4):352-356. PubMed ID: 34784875
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository.
de Azevedo Lopes E; Balbi GGM; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Gerosa M; Fortin PR; Lopez-Pedrera C; Ji L; Cohen H; de Jesús GR; Branch DW; Nalli C; Petri M; Rodriguez E; Kello N; Ríos-Garcés R; Knight JS; Atsumi T; Willis R; Bertolaccini ML; Erkan D; Andrade D;
Adv Rheumatol; 2021 Oct; 61(1):64. PubMed ID: 34711275
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for arterial thrombosis in antiphospholipid syndrome.
Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
[TBL] [Abstract][Full Text] [Related]
13. What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?
Amigo MC
Lupus; 2014 Oct; 23(12):1259-61. PubMed ID: 25228720
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients.
Vianna JL; Khamashta MA; Ordi-Ros J; Font J; Cervera R; Lopez-Soto A; Tolosa C; Franz J; Selva A; Ingelmo M
Am J Med; 1994 Jan; 96(1):3-9. PubMed ID: 8304360
[TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)].
Chwalińska-Sadowska H; Meissner M; Wudarski M; Zabek J; Wojciechowska B
Pol Arch Med Wewn; 2006 May; 115(5):401-6. PubMed ID: 17195351
[TBL] [Abstract][Full Text] [Related]
16. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
[TBL] [Abstract][Full Text] [Related]
17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome-Multicenter, Real-Life Long-Term Follow-Up.
Niznik S; Rapoport MJ; Avnery O; Lubetsky A; Haj Yahia S; Ellis MH; Agmon-Levin N
Front Immunol; 2022; 13():843718. PubMed ID: 35514968
[TBL] [Abstract][Full Text] [Related]
19. Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.
Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Tektonidou MG
Semin Arthritis Rheum; 2018 Jun; 47(6):883-889. PubMed ID: 29150207
[TBL] [Abstract][Full Text] [Related]
20. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
Reshetnyak T; Cheldieva F; Cherkasova M; Lila A; Nasonov E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
